These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 11135048

  • 1. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
    Moore T, Lee AH.
    Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
    [Abstract] [Full Text] [Related]

  • 2. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS, Tamsen A.
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [Abstract] [Full Text] [Related]

  • 3. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast.
    Lee AH.
    Histopathology; 2008 Jan; 52(1):45-57. PubMed ID: 18171416
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
    Tse GM, Tsang AK, Putti TC, Scolyer RA, Lui PC, Law BK, Karim RZ, Lee CS.
    J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
    [Abstract] [Full Text] [Related]

  • 10. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
    Ho SK, Thike AA, Cheok PY, Tse GM, Tan PH.
    Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
    [Abstract] [Full Text] [Related]

  • 11. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
    Kocová L, Skálová A, Fakan F, Rousarová M.
    Pathol Res Pract; 1998 Sep; 194(2):97-104. PubMed ID: 9584322
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phyllodes tumours of the breast: a consensus review.
    Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, Calvo JP, Dabbs DJ, Ellis IO, Eusebi V, Farshid G, Fox SB, Ichihara S, Lakhani SR, Rakha EA, Reis-Filho JS, Richardson AL, Sahin A, Schmitt FC, Schnitt SJ, Siziopikou KP, Soares FA, Tse GM, Vincent-Salomon A, Tan PH.
    Histopathology; 2016 Jan; 68(1):5-21. PubMed ID: 26768026
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
    Jara-Lazaro AR, Akhilesh M, Thike AA, Lui PC, Tse GM, Tan PH.
    Histopathology; 2010 Aug; 57(2):220-32. PubMed ID: 20716164
    [Abstract] [Full Text] [Related]

  • 17. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
    Lee AH, Hodi Z, Ellis IO, Elston CW.
    Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
    Kuijper A, van der Groep P, van der Wall E, van Diest PJ.
    Breast Cancer Res; 2005 Sep; 7(5):R808-18. PubMed ID: 16168127
    [Abstract] [Full Text] [Related]

  • 20. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
    Huang KT, Dobrovic A, Yan M, Karim RZ, Lee CS, Lakhani SR, Fox SB.
    Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.